Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2295 SEK | +20.54% | +13.61% | -97.70% |
10/05 | Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar | MT |
02/05 | Xbrane Biopharma AB Appoints Kristoffer Bissessar Was Elected as New Director | CI |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Trading Ideas